Submission of Matters to a Vote of Security Holders - Form 8-K

On April 23, 2024, Akili, Inc. (the "Company") received a letter from the Listing Qualifications Staff (the "Nasdaq Staff") of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it has been granted an additional 180-daycompliance period, or until October 21, 2024 (the "Extension Notice"), to regain compliance with Nasdaq's minimum closing bid price rule required by the continued listing requirements of Nasdaq Listing Rule 5550(a)(2) (the "Bid Price Requirement"). Nasdaq's determination follows the Company's recent request for such additional compliance period and is based, in part, on the Company's written notice to the Nasdaq Staff of its intention to cure the deficiency during the additional compliance period and if necessary, by effecting a reverse stock split.

Previously, on October 24, 2023, the Company received a written notification from Nasdaq notifying the Company that the bid price of the Company's common stock, par value $0.0001 per shares ("common stock") had closed below $1.00 per share for 30 consecutive business days and that the Company therefore was not in compliance with the Bid Price Requirement.

The Extension Notice has no immediate effect on the listing of the Company's common stock on the Nasdaq Capital Market, which will continue to be listed and traded on the Nasdaq Capital Market subject to the listing rules. To regain compliance, the closing bid price of the Company's common stock must be at least $1.00 per share for a minimum of 10 consecutive business days before October 21, 2024. If the Company does not regain compliance during the additional compliance period, then Nasdaq will notify the Company of its determination to delist the Company's common stock, at which point the Company would have an opportunity to appeal the delisting determination to a hearings panel. There can be no assurance that the Company will be successful in regaining compliance with the Nasdaq listing rules or in maintaining its listing of common stock on the Nasdaq Capital Market. The Company intends to actively monitor the closing bid price of its common stock and will evaluate available options to resolve the deficiency and regain compliance with the Bid Price Requirement.